CDCP1 and cancer: Together, our CDCP1 expression results suggest that clinical implementation of CDCP1 directed therapeutic agents will be facilitated by the availability of a screening protocol, such as molecular PET imaging, that is able to select cancer patients who have CDCP1 protein levels that are sufficiently elevated in tumors above normal organs.